At SynCell, we believe that the solution towards AMR is not in the form of traditional antibiotics.
  • We provide an innovative solution that uses the bacteria itself to fight the problem of antibiotic resistance.
  • By understanding the mechanisms of key biochemical processes in prokaryotic cells, we use bacteria as biofactories of nanomaterials without introducing any genetic manipulation in the organisms.
  • Once produced, the nanomaterials are purified and employed as either sole antimicrobials or key components in combinatorial medical devices.